Literature DB >> 11027630

Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes.

I Zelko1, M Negishi.   

Abstract

Phenobarbital (PB) increases metabolic capability of hepatocytes by its ability to activate numerous genes encoding various xenochemical-metabolizing enzymes such as cytochrome P450s and specific transferases. More than 35 years since PB induction was first reported, the key nuclear receptor CAR that mediates the induction has now been identified, and the molecular/cellular mechanism involving multiple signal transduction pathways has begun to be unraveled. In response to PB exposure, CAR in the cytoplasm translocates into the nucleus, forms a heterodimer with the retinoid X receptor, and activates the PB response enhancer element leading to the concerted induction of numerous genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027630     DOI: 10.1006/bbrc.2000.3557

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

3.  Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR.

Authors:  Aaron W Bell; George K Michalopoulos
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

4.  Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice.

Authors:  Heather E Kleiner; Xiaojun Xia; Junichiro Sonoda; Jun Zhang; Elizabeth Pontius; Jane Abey; Ronald M Evans; David D Moore; John DiGiovanni
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-15       Impact factor: 4.219

5.  Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.

Authors:  Bryan Mackowiak; Linhao Li; Matthew A Welch; Daochuan Li; Jace W Jones; Scott Heyward; Maureen A Kane; Peter W Swaan; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2017-04-25       Impact factor: 4.436

6.  Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers.

Authors:  Stephanie R Faucette; Tong-Cun Zhang; Rick Moore; Tatsuya Sueyoshi; Curtis J Omiecinski; Edward L LeCluyse; Masahiko Negishi; Hongbing Wang
Journal:  J Pharmacol Exp Ther       Date:  2006-10-13       Impact factor: 4.030

7.  Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3).

Authors:  Scott S Auerbach; Matthew A Stoner; Shengzhong Su; Curtis J Omiecinski
Journal:  Mol Pharmacol       Date:  2005-08-11       Impact factor: 4.436

8.  Nuclear receptor CAR specifically activates the two-pore K+ channel Kcnk1 gene in male mouse livers, which attenuates phenobarbital-induced hepatic hyperplasia.

Authors:  Kosuke Saito; Rick Moore; Masahiko Negishi
Journal:  Toxicol Sci       Date:  2013-01-04       Impact factor: 4.849

Review 9.  CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Authors:  Hongbing Wang; Leslie M Tompkins
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

Review 10.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.